HIV Testing Services Guideline
What is HIV?
Human Immunodeficiency Virus (HIV) is the virus that destroys the body’s defense system. When the entire body’s immune system is destroyed, this lead to AIDS.
What is AIDS?
Acquired Immune Deficiency Syndrome (AIDS) is a sickness that makes the body unable to fight any germ. When a person gets AIDS, any small sickness that is around may catch him/her. The body is not able to fight these sicknesses.
Where can I get tested for HIV/AIDS?
Select your County below to see the testing locations in your area:
- Grand Bassa
- Grand Cape Mount
- Grand Gedeh
- Grand Kru
- River Gee
How is HIV Spread?
- Unprotected sexual intercourse when one of the partners is infected
- Receiving infected blood
- Sharing used, unsterilized and infected needles, syringes and objects shaped like razor blades
- Parent-to-Child transmission during pregnancy, childbirth, and breast-feeding
Anyone can get HIV & AIDS…
You Cannot Get HIV From…
- Sharing a public toilet
- Sleeping together
- Bathing together
- Shaking hands
- A mosquito bite
- Eating together
Who is at Risk?
- People with STIs (Sexually Transmitted Infections), gonorrhea (GC), or people with sores on their private parts
- People who have unprotected sex
- People who inject recreational drugs
- Those who received infected blood or blood products
- Anyone whose sexual partner is infected with the virus
- Babies born by parents who are HIV positive
There is no vaccine or cure for HIV but HIV can be prevented & treated
How Can I Protect Myself?
- Abstain from sex until you are ready
- Stick to your faithful HIV-negative sexual partner
- Always use a condom correctly and consistently during sex
- Make sure any blood or blood product that you receive has been tested and is free of HIV
- Pre-Exposure Prophylaxis (Oral PrEP – is an additional Prevention methods)
- PrEP is the use of ARVs by people who are HIV negative to prevent the acquisition of HIV before exposure to the virus.
- Regimen for all clients using oral PrEP to prevent HIV acquisition from non-sexual exposures, all clients assigned female at birth (AFAB), and for clients AMAB who are using exogenous hormones
- Oral PrEP must be taken daily and should be used for at least seven consecutive days before it is considered effective. It must be continued for 7 days after the last potential exposure.
- Daily PrEP regimen for clients AMAB using oral PrEP to prevent HIV acquisition from sexual exposures and who are not using exogenous hormones
- Start daily oral PrEP with a loading dose of two pills at PrEP initiation and delay sex for at least two hours, at which time drug levels will be sufficient to prevent HIV acquisition from sexual exposures. Continue taking one pill of PrEP at the same time daily. To discontinue, continue one pill of PrEP daily until two days after the last potential sexual exposure
- How is it taken? -One pill is taken each day
- How is it for? -All populations
- What is it for? -Preventing HIV acquisition during all types of exposures
- Event-driven (ED)
- How is it taken? -Two pills are taken 2-24 hours before sex and then a pill following day until two days after the last potential sexual exposure
- Who is it for? -People assigned male at birth not using exogenous hormones*
- What is it for? –Preventing HIV acquisition during SEXUAL EXPOSURES ONLY
Get tested for HIV, know your status
Treatment is Here
HIV treatment is available and free at many health facilities inLiberia. The treatment can reduce the number of virus in the system and build the immune system. Once you are on treatment:
- It’s to be taken every day for life once you are tested HIV positive
- Do your viral load test six months from your treatment start date
- Viral load test will inform you if you are responding to the treatment
- Treatment can reduce the viral load to undetectable level and you cannot pass the virus to people sexually
The impact of the epidemic continues to be significant.
Spectrum Modeling estimates for 2017 revealed there will be 1,789 new HIV infections including 309 in children 0-14 years. About 57% of the new infections will be in females. There will be 29,538 PLHIV including 2,730 in young people 15-24 years and 4,784 children 0-14 years. About 56% of PLHIV are female. The 2013 LDHS reveals the total HIV prevalence is 1.9% (2% in women and 1.7% in men), up from 1.5% in 2007. The HIV prevalence amongst pregnant women has decreased from a peak of 5.4% in 2007 to 2.5% in 2013; this is mirrored by a moderate decrease in the mother to child HIV transmission rate at the cessation of breastfeeding from 37% in 2009 to 29% in 2013. An estimated 2,330 PLHIV (including 52% female) will die from AIDS-related causes with 97% of the deaths occurring in PLHIV not on treatment. Cumulatively, there will be 38,462 AIDS-orphans in 2014, equivalent to about 19% of total orphans from all causes.
Since 2009, HCT, PMTCT, ART, PEP, STIs, services are being systematically scaled up and services are provided at designated GOL, FBO, and private health facilities throughout the country. Coverage of HCT, PMTCT, and ART services has increased slowly since 2009. HCT coverage has increased from 3% in 2009 to 10% in 2013 to , PMTCT from 13% in 2009 to 64% in 2013, and adult ART from 25% in 2009 to 35% in 2013.
Cohort Article information
You must be logged in to post a comment.